阿尔法-比萨博醇通过抑制气道炎症信号来保护新生儿喘
Rekha Thiruvengadam1,2, Mydhili Govindarasu3, Jamal Mohammed Ali Khaled4
1Centre for Global Health Research-Helix Research Lab, Department of Neonatology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600077, India.
International journal of medical sciences
|August 6, 2025
概括
阿尔法-比萨博 (AB) 有效地降低了过敏呼吸道炎症的小鼠的炎症和氧化应激. 这表明AB通过抑制疾病发作期间的炎症反应来保护新生儿喘.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 新生儿喘涉及复杂的炎症途径.
- 阿尔法-比萨博醇 (AB) 是一种具有潜在抗炎性能的天然化合物.
研究的目的:
- 评估阿尔法-比萨博醇 (AB) 对幼鼠过敏气道炎症的保护作用.
- 在新生儿喘模型中研究AB对炎症标志物和细胞透的影响.
主要方法:
- 雄性Wistar小鼠被分为四组:载体控制,AB治疗控制,诱导过敏气道炎症和AB预治疗诱导过敏气道炎症.
- 评估包括肺部组织病理学,支气管支气管洗液等离子素计数,以及炎症标志物和基因转录的测量.
- 评估的特定炎症标志物包括IL-1β,IL-6,IL-8,IL-17,MCP-1,CXCR4,TSLP,COX-2,TNF-α,TLR4,Eotaxin-1和RANTES. 这三种类型的炎症标志物.
主要成果:
- AB预治疗显著降低了粘膜腺缩和埃索诺菲尔在肺部的透.
- AB显著抑制了高水平的促炎细胞因子 (IL-1β,IL-6,IL-8,IL-17,MCP-1,CXCR4,TSLP) 和氧化应激标志物.
- 关键炎症基因的转录,包括循环氧化原酶-2,瘤亡因子-α,CXCR4,类似收费受体4,Eotaxin-1和RANTES,在AB预处理中被显著抑制.
结论:
- 阿尔法-比萨博显示出显著的抗炎和保护作用,对新生儿过敏气道炎症.
- AB抑制了关键的炎症通路,包括细胞因子信号传递和氧化应激,表明其作为新生儿喘治疗剂的潜力.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
386
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
386
01:19Antiasthma Drugs: Leukotriene Modifiers
475
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
475
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
461
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
461
01:20Asthma: Pathogenesis and Management
593
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
593
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
394
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
394
01:17Drugs Used in Lower Respiratory Disorders: Overview
583
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
583